M
Meng Zhou
Researcher at University of Miami
Publications - 74
Citations - 6400
Meng Zhou is an academic researcher from University of Miami. The author has contributed to research in topics: Nanoclusters & Excited state. The author has an hindex of 30, co-authored 71 publications receiving 4457 citations. Previous affiliations of Meng Zhou include Chinese Academy of Sciences & Northeast Normal University.
Papers
More filters
Journal ArticleDOI
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
TL;DR: This review summarizes the major progress in the field, including the principles that permit atomically precise synthesis, new types of atomic structures, and unique physical and chemical properties ofatomically precise nanoparticles, as well as exciting opportunities for nanochemists to understand very fundamental science of colloidal nanoparticles.
Journal ArticleDOI
H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
TL;DR: It is shown that natural H-ferritin (HFn) nanocages can carry high doses of doxorubicin (Dox) for tumor-specific targeting and killing without any targeting ligand functionalization or property modulation, which makes the HFn nanocage an ideal vehicle for efficient anticancer drug delivery.
Journal ArticleDOI
Manipulating aggregation and molecular orientation in all-polymer photovoltaic cells.
Long Ye,Xuechen Jiao,Meng Zhou,Shaoqing Zhang,Huifeng Yao,Wenchao Zhao,Andong Xia,Harald Ade,Jianhui Hou +8 more
TL;DR: By replacing the polymeric donor PBDTBDD with its 2D-conjugated polymer PBDD-T, the power conversion efficiency of OPVs featuring the anisotropic polymer acceptor PNDI is drastically boosted from 2.4% up to 5.8%.
Journal ArticleDOI
Crystal structure of a luminescent thiolated Ag nanocluster with an octahedral Ag64+ core
TL;DR: A yellow luminescent thiolate-protected Ag(14)(SC(6)H(3)F(2))(12)(PPh(3))(8) cluster was synthesized and structurally characterized by single-crystal X-ray analysis.
Journal ArticleDOI
Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.
TL;DR: H-ferritin (HFn) nanocarrier both successfully crosses the blood brain barrier and kills glioma tumor cells, and possesses the potential to serve as a therapeutic approach against a broad range of central nervous system diseases.